SCHEMBL27615862

SCHEMBL27615862

Cc1cc(NC(=O)O)c(NC(=O)CC(=O)c2cccc(-c3ccc(C4CC4)nc3)c2)cc1Cl

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.39
ALDH1A1 P00352 2/20 0.39
NPC1 O15118 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
DRD4 P21917 4/20 0.36
POLB P06746 1/20 0.36
MAPT P10636 2/20 0.36
LMNA P02545 1/20 0.36
IRAK4 Q9NWZ3 1/20 0.36
DRD2 P14416 1/20 0.36
WNT3A P56704 2/20 0.36
HSD17B13 Q7Z5P4 1/20 0.35
NR1H4 Q96RI1 1/20 0.35
PTGES O14684 1/20 0.35
MAPK1 P28482 1/20 0.35
IDO1 P14902 1/20 0.35
GRIN2B Q13224 1/20 0.35
ADORA2A P29274 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5562825 0.89 POLB (0.35) DRD4POLBMAPTLMNADRD2
SCHEMBL28754186 0.87 POLB (0.40) RAB9APOLBWNT3APTGESIDO1
SCHEMBL27615901 0.85 RAB9A (0.41) RAB9AALDH1A1NPC1SMN1; SMN2MEN1
SCHEMBL27615907 0.84 RAB9A (0.40) RAB9AALDH1A1NPC1SMN1; SMN2MEN1
SCHEMBL27615925 0.83 POLB (0.39) POLBWNT3APTGESIDO1
SCHEMBL27615982 0.82 MEN1 (0.46) ALDH1A1MEN1KMT2APOLBIDO1
SCHEMBL27615869 0.81 WNT3A (0.44) RAB9AALDH1A1NPC1SMN1; SMN2MEN1
SCHEMBL27615835 0.81 WNT3A (0.44) RAB9AALDH1A1NPC1SMN1; SMN2MEN1
SCHEMBL27597134 0.79 RAB9A (0.42) RAB9AALDH1A1NPC1SMN1; SMN2MEN1
SCHEMBL27597164 0.79 ALDH1A1 (0.45) RAB9AALDH1A1NPC1SMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100497333-C Dihydrobenzodiazepin-2-one derivatives for the treatment of neurological disorders HOFFMANN LA ROCHE (CH) 2009-06-10 CN disclosed
CN-1633430-A Dihydrobenzodiazepin-2-one derivatives for the treatment of neurological disorders HOFFMANN LA ROCHE (CH) 2005-06-29 CN disclosed